Single crystals of the dipotassium salt of gluocose-1-phosphate were grown out of water or deuterium oxide and x-irradiated at 4.2 °K. The products of irradiation were identified by means of ESR and ENDOR spectroscopy. In crystals grown out of water, three different alkoxy radicals were observed as oxidation products. In partially deuterated crystals only one of the aforementioned alkoxy radicals was produced. A hydroxyalkyl radical, RHĊOH was also produced by loss of hydrogen from the C6′ position. Electrons trapped at intermolecular sites were identified. The distances between the electron and the protons of the polar hydroxy groups forming the trap were deduced from ENDOR measurements and found to be relatively large, namely 1.732 and 1.738 Å.

Purpose: Historically, the standard of care for total skin electron beam therapy (TSEBT) delivered 30 to 36 Gy over 5 to 10 weeks. Given the high risk of relapse, a majority of patients require additional treatments. Therefore, attempts to use a shortened course of TSEBT have been investigated. Methods and Materials: We conducted a single-institution retrospective review to evaluate disease response, control, and toxicity using a low-dose, hypofractionated course of TSEBT (HTSEBT) in patients with mycosis fungoides. Results: Forty patients received 57 courses of HTSEBT. Median dose (Gy)/fractionation was 12/3, spanning a median time of 2.4 weeks. Overall response rate of patients assessed (n Z 54) was 100%. Thirty-one courses (57.4%) resulted in a complete response and 23 courses (42.6%) resulted in a partial response. Cumulative incidence of progressive skin disease at 3 months was 37.2%, at 6 months, 56.9%, and at 1 year, 81.5%. Of the 40 patients treated with a first course of HTSEBT, 31 received subsequent courses of radiotherapy. Cumulative incidence of subsequent treatment was 28.0% at 3 months, 46.8% at 6 months, and 70.0% at 1 year. Patients who underwent repeat courses of HTSEBT continued to have similar treatment responses to repeat courses without increased toxicities. Toxicities from all courses were acceptable with the exception of 1 patient, who experienced grade 4 skin toxicity (moist desquamation requiring hospitalization). Conclusions: Low-dose HTSEBT provides good palliation in patients with cutaneous T-cell lymphoma with a satisfactory response and toxicity profile. HTSEBT allows therapy to be completed in far fewer treatments. Low-dose HTSEBT is an appropriate treatment option for patients unable to come for daily treatment. HTSEBT provides a way to decrease exposure to other patients and staff during public health emergencies such as the coronavirus disease 2019 (COVID-19) pandemic.

By this technique it is possible to achieve an undistorted image of each aspect of the acetabular rim. Regions of special interest can be defined and their pathologies possibly related to morphologies of the proximal end of the femur.

No abstract

No abstract